Kevin Haas is the Director of Bioinformatics at Counsyl, developing innovative methods and algorithms for Counsyl’s analytic pipeline. He was previously Director of Software Engineering at Counsyl, building the advanced systems which power its next generation sequencing lab. He earned his BS in Chemistry and Chemical engineering from UW-Madison and his PhD in Chemical Engineering from UC-Berkeley where he concentrated on the Statistical Learning Theory of Protein Dynamics. He also serves as the Treasurer on the Board of Directors for the non-profit USA Triathlon.

David Vivero is co-founder and CEO at Amino, a healthcare transparency company working to connect everyone to better, more affordable care. David currently guides the vision and direction of the company and its personalized, data-driven products that help people estimate their costs and book appointments with experienced doctors. Previously, David was VP of Rentals at Zillow, responsible for the world’s largest online rental marketplace, following the acquisition of RentJuice, a company he cofounded in 2008. David is also a General Partner at Red Swan Ventures. David has a BA and MBA from Harvard University.

Deanna Church is the Senior Director of Applications at 10x Genomics. Before that, she was Senior Director of Genomics and Content at Personalis. She was previously a staff scientist at NCBI, where she oversaw several projects concerning managing and displaying genomic data. Dr. Church was also a member of the Genome Reference Consortium (GRC) an international consortium charged with improving the human, mouse and zebrafish assemblies, and was an author on the two seminal manuscripts describing the human and mouse genome sequences. She has experience in molecular biology, genetics, genomics, bioinformatics, and is currently focusing on improving genome analysis. She graduated from the University of Virginia with a BA in Liberal Arts and received her doctoral degree in the Biological Sciences at the University of California, Irvine with Dr. John Wasmuth. She performed postdoctoral work with Dr. Janet Rossant at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto.

Dale Webster is a Staff Software Engineer at Google working on Deep Learning for Medical Imaging. Prior to that he was a Senior Software Engineer in Bioinformatics at Pacific Biosciences where he worked on data mining and software development enabling the launch of the PacBio RS DNA sequencing machine. He studied at the University of California San Francisco, where his research focused on viral evolution.

Jonathan Krause is a Software Engineer at Google working on medical imaging. He previously graduated from Stanford with a PhD in computer vision and deep learning, where his research centered on fine-grained recognition, the task of differentiating very similar object categories in images.

Dr. Guinney is the Director of Computational Oncology at Sage Bionetworks. His research is focused on the development of integrative modeling approaches in cancer using large-scale biomedical and high-throughput genomic data. Dr. Guinney is also a co-director of the DREAM Challenges, and has led several challenges related to cancer prognosis, combination therapy, and image analysis. He has a BA in history from the University of Pennsylvania, a BS in electrical engineering from the University of Illinois Urbana-Champaign, and a PhD in Computational Biology and Bioinformatics from Duke University.

Francisco Gimenez is a principal on the investment team at 8VC focusing on biotech and life science investments. He was previously their Resident Data Scientist where he helped portfolio companies strategize, prototype, and recruit data science teams across multiple domains. He also was founder of Catenus Science, a data science consulting and recruiting firm for early stage startups. Francisco received his PhD from Stanford in Biomedical Informatics, where he was a Ruth L. Kirchstein Fellow. Prior to that he got his BS in Electrical Engineering and Computer Sciences from UC Berkeley.

David Heckerman is Chief Data Scientist at Human Longevity, Inc (HLI). He is known for his work in showing the importance of probability theory in Artificial Intelligence, for developing methods to learn graphical models from data, and for developing machine learning and statistical approaches for biological and medical applications, including the design of a vaccine for HIV. For the past twelve years, he has been working on computational tools for genomics. Before HLI, David had been working at Microsoft since 1992, where he created the first machine learning research group (1994) and the first bioscience research group (2004). At Microsoft, he developed numerous applications including the junk-mail filters in Outlook, Exchange, and Hotmail, machine-learning tools in SQL Server and Commerce Server, handwriting recognition in the Tablet PC, text mining software in Sharepoint Portal Server, troubleshooters in Windows, and the Answer Wizard in Office. David received his Ph.D. (1990) and M.D. (1992) from Stanford University, and is a Fellow of ACM and AAAI.

Patrick Ryan is Senior Director of Epidemiology and the Head of Epidemiology Analytics at Janssen Research and Development, where he is leading efforts to develop and apply analysis methods to better understand the real-world effects of medical products. He is currently a collaborator in Observational Health Data Sciences and Informatics (OHDSI), a multi-stakeholder, interdisciplinary collaborative to create open-source solutions that bring out the value of observational health data through large-scale analytics. He served as a principal investigator of the Observational Medical Outcomes Partnership (OMOP), where he led methodological research to assess the appropriate use of observational health care data to identify and evaluate drug safety issues. Patrick received his undergraduate degrees in Computer Science and Operations Research at Cornell University, his Master of Engineering in Operations Research and Industrial Engineering at Cornell, and his PhD in Pharmaceutical Outcomes and Policy from University of North Carolina at Chapel Hill. Patrick has worked in various positions within the pharmaceutical industry at Pfizer and GlaxoSmithKline, and also in academia at the University of Arizona Arthritis Center.